FDA recommends discontinuation of OTC Zantac

The FDA has requested that manufacturers withdraw all prescription and over-the-counter ranitidine drugs and advised patients to discontinue taking over-the-counter versions of the drug, according to an agency release.This move is the most recent step in the agency’s ongoing investigation of N-Nitrosodimethylamine (NDMA) contamination in ranitidine medications, according to an agency safety alert. The FDA…

Guest Commentary: Managing a private practice during the COVID-19 pandemic

In this Guest Commentary, Peter R. Honig, DO, a family physician with a private practice in Philadelphia, spoke with Healio Primary Care about the strategies he is using to manage his practice during the COVID-19 pandemic.Three weeks ago, I was driving back from vacation in Canada with my wife, who is also a medical provider….